A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Titel:
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Auteur:
Voss, M.H. Hussain, A. Vogelzang, N. Lee, J.L. Keam, B. Rha, S.Y. Vaishampayan, U. Harris, W.B. Richey, S. Randall, J.M. Shaffer, D. Cohn, A. Crowell, T. Li, J. Senderowicz, A. Stone, E. Figlin, R. Motzer, R.J. Haas, N.B. Hutson, T.